World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
34415
World Ranking
10822
National Ranking
5571

Joan W. Miller publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Joan W. Miller sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 590 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Joan W. Miller D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Joan W. Miller sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Joan W. Miller is affiliated with the Massachusetts Eye and Ear Infirmary in the United States. Their research primarily lies within the field of Medicine, with a significant focus on ophthalmology and related areas.

The main subfields of their work include:

  • Ophthalmology
  • Radiology, Nuclear Medicine and Imaging
  • Molecular Biology
  • Epidemiology
  • Neurology

Joan W. Miller has contributed to a variety of topics within ophthalmic research, including:

  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Glaucoma and retinal disorders
  • Retinal and Optic Conditions
  • Corneal surgery and disorders
  • Intraocular Surgery and Lenses
  • Ophthalmology and Visual Impairment Studies

Their frequent co-authors consist of:

  • Anja Lorch
  • Demetrios G. Vavvas
  • Tobias Elze
  • John B. Miller
  • Deeba Husain

Joan W. Miller has published extensively in prominent ophthalmology journals. Some of the frequent publication venues include:

  • Ophthalmology
  • Ophthalmology Science
  • American Journal of Ophthalmology
  • British Journal of Ophthalmology
  • Ophthalmology Glaucoma

Recent publications by Joan W. Miller include:

  • Retinal applications of swept source optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA), 2021, Progress in Retinal and Eye Research
  • Comparison of widefield swept-source optical coherence tomography angiography with ultra-widefield colour fundus photography and fluorescein angiography for detection of lesions in diabetic retinopathy, 2020, British Journal of Ophthalmology
  • Trends and Usage Patterns of Minimally Invasive Glaucoma Surgery in the United States, 2021, Ophthalmology Glaucoma
  • Dyslipidemia in age-related macular degeneration, 2022, Eye
  • Race and Ethnicity Differences in Disease Severity and Visual Field Progression Among Glaucoma Patients, 2022, American Journal of Ophthalmology

Best Publications

  • Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy

    Anthony P. Adamis;Anthony P. Adamis;Joan W. Miller;Maria-Teresa Bernal;Donald J. D'Amico

  • Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.

    Joan W. Miller;Anthony P. Adamis;David T. Shima;Patricia A. D'Amore

  • Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate

    Anthony P. Adamis;David T. Shima;Michael J. Tolentino;Evangelos S. Gragoudas

  • Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

    Magdalena G. Krzystolik;Mehran A. Afshari;Anthony P. Adamis;Jacques Gaudreault

  • INTRAVITREOUS INJECTIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCE RETINAL ISCHEMIA AND MICROANGIOPATHY IN AN ADULT PRIMATE

    Michael J. Tolentino;Michael J. Tolentino;Joan W. Miller;Evangelos S. Gragoudas;Frederick A. Jakobiec

  • Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration

    Wei Chen;Dwight Stambolian;Albert O. Edwards;Kari E. Branham

  • Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration

    Daniel F. Martin;Michael Klein;Julia Haller;Anthony Adamis

  • VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization.

    Susumu Ishida;Tomohiko Usui;Tomohiko Usui;Kenji Yamashiro;Kenji Yamashiro;Yuichi Kaji;Yuichi Kaji

  • Tumor Necrosis Factor-α Mediates Oligodendrocyte Death and Delayed Retinal Ganglion Cell Loss in a Mouse Model of Glaucoma

    Toru Nakazawa;Chifuyu Nakazawa;Akihisa Matsubara;Kousuke Noda

  • Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin - 1-year results of a randomized clinical trial - VIP report no. 1

    J. Arnold;D. Kilmartin;J. Olson;S. Neville

  • Diffusion of High Molecular Weight Compounds through Sclera

    Jayakrishna Ambati;Christina S. Canakis;Joan W. Miller;Evangelos S. Gragoudas

  • Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular Degeneration: Results of a Single Treatment in a Phase 1 and 2 Study

    Ursula Schmidt-Erfurth;Joan W. Miller;Michel Sickenberg;Horst Laqua

  • Vascular endothelial growth factor a in intraocular vascular disease.

    Joan W. Miller;Jennifer Le Couter;Erich C. Strauss;Napoleone Ferrara

  • Vascular Endothelial Growth Factor Is Sufficient to Produce Iris Neovascularization and Neovascular Glaucoma in a Nonhuman Primate

    Michael J. Tolentino;Joan W. Miller;Evangelos S. Gragoudas;Klio Chatzistefanou

  • Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.

    Kevin J. Blinder;Mark S. Blumenkranz;Neil M. Bressler;Susan B. Bressler

  • Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.

    Blinder Kj;Bradley S;Bressler Nm;Bressler Sb

  • Vascular Endothelial Growth Factor in Ocular Neovascularization and Proliferative Diabetic Retinopathy

    Joan W. Miller;Anthony P. Adamis;Lloyd Paul Aiello;Lloyd Paul Aiello

  • Anti-vascular endothelial growth factor therapy for ocular neovascular disease.

    Christopher M Andreoli;Joan W Miller

  • Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy

    P Adamis;J W Miller;M T Bernal;D J D Amico

  • Intravitreous Injections of Vascular Endothelial Growth Factor Produce Retinal Ischemia and Microangiopathy in an Adult Primate.

    M J Tolentino;J W Miller;E S Gragoudas;F A Jakobiec

Frequent Co-Authors

Evangelos S. Gragoudas
Evangelos S. Gragoudas Massachusetts Eye and Ear Infirmary
Thaddeus P. Dryja
Thaddeus P. Dryja Massachusetts Eye and Ear Infirmary
Jurg Ott
Jurg Ott Rockefeller University
Constantine S. Mitsiades
Constantine S. Mitsiades Harvard University
Philip J. Rosenfeld
Philip J. Rosenfeld University of Miami
Ursula Schmidt-Erfurth
Ursula Schmidt-Erfurth Medical University of Vienna
Lindsay A. Farrer
Lindsay A. Farrer Boston University
Thomas J. Flotte
Thomas J. Flotte Mayo Clinic
Tatsuro Ishibashi
Tatsuro Ishibashi Kyushu University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re drawn to healthcare but want alternative pathways beyond traditional medical school, there are several rewarding options to consider. Many students explore specialized training or degree programs that offer flexibility, shorter completion times, and online study.

For those interested in the administrative side of healthcare, pursuing a degree in healthcare administration can open doors to leadership roles in hospitals, clinics, and other healthcare organizations.

Fast-track programs such as asn to np programs let registered nurses advance their qualifications and take on greater responsibilities as nurse practitioners, often through convenient online bridge options.

If you’re already an LPN (Licensed Practical Nurse), you may wish to upgrade your credentials without standardized testing requirements via lpn to rn programs without teas test, speeding up your transition to a registered nurse role.

For those intrigued by the business side of healthcare, online programs in medical billing and coding financial aid are a practical route, especially for anyone seeking in-demand remote work options. These alternative careers can be ideal stepping stones to broader opportunities within the healthcare sector.

Best Scientists Citing Joan W. Miller

Trending Scientists

Recently Published Articles